{
    "body": "Which disease of the central nervous system is characterized by the presence of Lewy bodies?", 
    "documents": [
        "http://www.ncbi.nlm.nih.gov/pubmed/2085926", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22355263", 
        "http://www.ncbi.nlm.nih.gov/pubmed/22251432", 
        "http://www.ncbi.nlm.nih.gov/pubmed/25514659", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23281786", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23979994", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23587141", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24465140", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23225525", 
        "http://www.ncbi.nlm.nih.gov/pubmed/24291999", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19877240", 
        "http://www.ncbi.nlm.nih.gov/pubmed/20174468", 
        "http://www.ncbi.nlm.nih.gov/pubmed/19155272", 
        "http://www.ncbi.nlm.nih.gov/pubmed/23531432", 
        "http://www.ncbi.nlm.nih.gov/pubmed/10986355", 
        "http://www.ncbi.nlm.nih.gov/pubmed/1534893"
    ], 
    "ideal_answer": [
        "Parkinson s disease (PD) is one of the most common degenerative disorders of the central nervous system that produces motor and non-motor symptoms. The majority of cases are idiopathic and characterized by the presence of Lewy bodies containing fibrillar \u03b1-synuclein  ", 
        "Parkinson's disease (PD) is one of the most common degenerative disorders of the central nervous system that produces motor and non-motor symptoms. The majority of cases are idiopathic and characterized by the presence of Lewy bodies containing fibrillar \u03b1-synuclein.", 
        "Parkinsons disease (PD) is one of the most common degenerative disorders of the central nervous system that produces motor and non-motor symptoms. The protein \u03b1-synuclein is well recognized to contribute to the pathogenesis of Parkinson disease and is the major component of Lewy bodies and Lewy neurites"
    ], 
    "exact_answer": [
        "Parkinson's disease (PD)"
    ], 
    "concepts": [
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002490", 
        "http://www.disease-ontology.org/api/metadata/DOID:12217", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D002493", 
        "http://www.disease-ontology.org/api/metadata/DOID:331", 
        "http://www.nlm.nih.gov/cgi/mesh/2015/MB_cgi?field=uid&exact=Find+Exact+Term&term=D020961"
    ], 
    "type": "factoid", 
    "id": "550c3754a103b78016000007", 
    "snippets": [
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 266, 
            "text": "Parkinson's disease (PD) is one of the most common degenerative disorders of the central nervous system that produces motor and non-motor symptoms. The majority of cases are idiopathic and characterized by the presence of Lewy bodies containing fibrillar \u03b1-synuclein", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23979994", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 106, 
            "text": "Parkinson's disease is characterized by \u03b1-synuclein pathology in the form of Lewy bodies and Lewy neurites", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23587141", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 157, 
            "text": "Parkinson's disease is characterized by neuronal death in the substantia nigra and the presence of intracellular inclusions of \u03b1-synuclein in the Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23531432", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 286, 
            "text": "Parkinson's disease, also known as paralysis agitans, is a progressive degenerative disorder of the central nervous system, with onset usually between the ages of 50 and 65 years, and is associated with loss of dopaminergic neurons in the subsantia nigra and the presence of Lewy bodies", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23281786", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 961, 
            "offsetInEndSection": 1118, 
            "text": "The protein \u03b1-synuclein is well recognized to contribute to the pathogenesis of Parkinson disease and is the major component of Lewy bodies and Lewy neurites", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/23225525", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 179, 
            "text": "Parkinson's disease (PD) and related Lewy body diseases are characterized by deposition of \u03b1-synuclein aggregates in both the central nervous system and peripheral nervous system.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24465140", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 202, 
            "text": "Parkinsons disease (PD) and dementia with Lewy bodies are common disorders of the aging population and characterized by the progressive accumulation of \ufffd-synuclein (\ufffd-syn) in the central nervous system.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22251432", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 143, 
            "offsetInEndSection": 343, 
            "text": "AF-LB and Parkinsons disease (PD) share the neuropathological findings characterized by widely distributed Lewy bodies in the central nervous system including the substantia nigra and locus coeruleus.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/2085926", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 189, 
            "text": "Parkinsons disease (PD) and dementia with Lewy bodies (DLB) are characterized by abnormal deposition of \ufffd-synuclein aggregates in many regions of the central and peripheral nervous systems.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/22355263", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 284, 
            "text": "A number of neurodegenerative diseases including Parkinsons disease, dementia with Lewy bodies (DLB) and multiple system atrophy are characterized by the formation and intraneuronal accumulation of fibrillar aggregates of alpha-synuclein (alpha-syn) protein in affected brain regions.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19155272", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 199, 
            "offsetInEndSection": 452, 
            "text": "They have been a long time the hallmark of Parkinsons disease, but in recent years it has emerged that a small group of rare disorders or rare variants of common degenerative diseases are also sometimes associated with Lewy bodies in the nervous system.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/1534893", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 206, 
            "text": "BACKGROUND: Lewy body disease is a heterogeneous group of neurodegenerative disorders characterized by alpha-synuclein accumulation that includes dementia with Lewy bodies (DLB) and Parkinsons Disease (PD).", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/20174468", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 262, 
            "text": "Although Parkinsons disease with later dementia (PDD) and dementia with Lewy bodies (DLB) are pathologically characterized by the presence of intraneuronal Lewy inclusion bodies, amyloid deposition is also associated to varying degrees with both these disorders.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/19877240", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 136, 
            "text": "Parkinsons disease (PD) is a neurodegnerative disorder that is pathologically characterized by the presence of Lewy bodies in the brain.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/10986355", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 487, 
            "offsetInEndSection": 962, 
            "text": "However, it seems that Braak staging can not explain difference in severity of autonomic failure between DLB and PD. As a possibility, in DLB patients with significant autonomic failure, Lewy bodies may have been localized to the peripheral autonomic nervous system in a long time before onset of dementia or parkinsonism, and propagation of Lewy bodies into the central nervous system may be initiated by apparition of certain promotion factor, such as ageing and amyloid-\ufffd.", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24291999", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 0, 
            "offsetInEndSection": 341, 
            "text": "Parkinson's disease (PD) is the second most common neurodegenerative disorder that is characterized by two major neuropathological hallmarks: the degeneration of dopaminergic neurons in the substantia nigra (SN) and the presence of Lewy bodies in the surviving SN neurons, as well as other regions of the central and peripheral nervous system", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/25514659", 
            "endSection": "abstract"
        }, 
        {
            "offsetInBeginSection": 706, 
            "offsetInEndSection": 942, 
            "text": "These include multiple system atrophy (MSA), characterized by accumulation of glial cytoplasmic inclusions, and Lewy body disorders, including Parkinson disease (PD), dementia with Lewy bodies, and the so-called \"pure\" autonomic failure", 
            "beginSection": "abstract", 
            "document": "http://www.ncbi.nlm.nih.gov/pubmed/24095115", 
            "endSection": "abstract"
        }
    ]
}